Contour® next GEN 血糖监测系统
K号: K193407 · 2021-12-23
广告
器械摘要
常见问题
What is the Contour® next GEN Blood Glucose Monitoring System?
Contour® next GEN Blood Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2021-12-23. The listed applicant is Ascensia Diabetes Care. The 510(k) number is K193407.
When did Contour® next GEN Blood Glucose Monitoring System receive FDA 510(k) clearance?
Contour® next GEN Blood Glucose Monitoring System received FDA 510(k) clearance on 2021-12-23, under 510(k) number K193407.
Who is the listed applicant for Contour® next GEN Blood Glucose Monitoring System?
FDA 510(k)记录显示Ascensia Diabetes Care为申请人。这本身并不能确立该设备制造商的身份。
What is the FDA product code for Contour® next GEN Blood Glucose Monitoring System?
The FDA product code for Contour® next GEN Blood Glucose Monitoring System is NBW. This falls under the OB/GYN category.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
列明Ascensia Diabetes Care为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
相关器械(代码:NBW)
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。
广告